Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105154514A enables high-purity (S)-5-methyl-1-aminoindane via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN111170829B details a safer, high-selectivity route for hexamethylindanol using supported Ru catalysts, offering significant cost and safety advantages for fragrance manufacturers.
Patent CN102206185A reveals a dual-solvent recrystallization method achieving >99.6% purity and <0.2% impurities for cataract drug intermediates.
Improved process for 1,2-indane carboxylic acids via chiral auxiliaries. Enhances yield and scalability for pharmaceutical intermediate manufacturing.
Patent CN119095829A reveals safer chlorination route. Reduces impurities and enhances supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN108659046B reveals a robust route for tetramethyl spiroindane ligands. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis.
Patent CN102603509B reveals a 3-step synthesis for high-purity photoinitiators, offering significant cost reduction and supply chain reliability for UV curing applications.
Patent CN111170886B details a novel mild oxidation and demethylation route for dezocine impurities, ensuring high purity and scalable pharmaceutical intermediate manufacturing.
Advanced preparation method for Zoledronic Acid Impurity B via optimized phosphorylation. High purity >98% reference standards for global pharmaceutical quality control.
Advanced 5-step synthesis of Terbutaline Sulfate Impurity B via patent CN115010665A. High purity standards, scalable route, and cost-effective manufacturing for global QC labs.
Patent CN112625086A reveals a high-purity enzymatic route for Argatroban Impurity G. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN109485616B details a novel SFC purification method for Etodolac photodegradation impurities, ensuring 99% purity and stable supply for pharmaceutical quality control.
Patent CN110028457B reveals a high-yield, three-step synthesis for isotope-labeled sulfadimidine, offering superior purity for veterinary drug analysis and supply chain stability.
Patent CN101597226B reveals a streamlined 2-step synthesis of 6-hydroxy-1-indanone from phenol, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturing.
Patent CN101597226A reveals a novel TfOH-catalyzed cyclization route for 6-hydroxy-1-indanone, offering a streamlined alternative to traditional multi-step amino or methoxy precursor methods for cost-effective manufacturing.
Patent CN115093313A discloses high-enantioselectivity rhodium catalysts for C-H activation, offering scalable routes for pharmaceutical intermediates.
Patent CN103044193B reveals a room-temperature zinc-catalyzed method for chiral secondary alcohols, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Novel low-pollution route for Oxibendazole using m-dichlorobenzene. Reduces cost and environmental impact for veterinary drug manufacturing.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN108690100A reveals a novel acetyl-protection route for Fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.